Zimmer to train Chinese device regulators

Zimmer ($ZMH) will help train Chinese regulators about orthopedic device developmental standards in an unusual deal recently announced by the company. But both parties will also conduct a sort of information exchange. As part of the memorandum of agreement, the Beijing Drug Administration will train Zimmer about Chinese laws and regulations concerning medical device sales. In return, Zimmer will offer training focused on medical device research, development, inspection, clinical use and quality control. Chinese regulators are hoping to boost local medical device companies' expertise regarding both production and regulatory inspections, in order to enhance safety and quality. Zimmer makes orthopedic, spinal and trauma devices, as well as dental implants and related surgical products. Release

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.